- Previous close
0.0210 - Open
0.0240 - Bid 0.0230 x --
- Ask 0.0240 x --
- Day's range
0.0230 - 0.0260 - 52-week range
0.0150 - 0.0600 - Volume
5,685,300 - Avg. Volume
4,276,729 - Market cap (intra-day)
14.719M - Beta (5Y monthly) 0.26
- PE ratio (TTM)
-- - EPS (TTM)
-0.0100 - Earnings date 12 Nov 2024 - 18 Nov 2024
- Forward dividend & yield --
- Ex-dividend date 19 Aug 2022
- 1y target est
--
Livingstone Health Holdings Limited, an investment holding company, provides medical treatment and consultancy services in Singapore. The company operates through Specialist Healthcare, Primary Healthcare, and Others segments. It offers various medical services in the fields of anesthesiology and pain management, orthopedic surgery, dermatology, internal medicine, primary and preventive care, disease management, podiatry, physiotherapy, respiratory, musculoskeletal, chronic conditions, gastrointestinal infections, and aesthetics and wellness through primary care clinics, family medicine, private medical specialists, and allied health care professionals. The company also provides other paramedical products and services, such as project consultancy services; and management, medical treatment consultancy, and management consultancy services. It operates with a network of medical doctors and healthcare professionals. The company was incorporated in 2004 and is headquartered in Singapore.
www.livingstonehealth.com.sg95
Full-time employees
31 March
Fiscal year ends
Healthcare
Sector
Medical Care Facilities
Industry
Related news
View more
Performance overview: PRH.SI
Trailing total returns as of 08/11/2024, which may include dividends or other distributions. Benchmark is
.YTD return
1-year return
3-year return
5-year return
Compare to: PRH.SI
Select to analyse similar companies using key performance metrics; select up to four stocks.
Statistics: PRH.SI
View moreValuation measures
Market cap
12.88M
Enterprise value
18.49M
Trailing P/E
--
Forward P/E
--
PEG ratio (5-yr expected)
--
Price/sales (ttm)
0.37
Price/book (mrq)
3.44
Enterprise value/revenue
0.73
Enterprise value/EBITDA
5.16
Financial highlights
Profitability and income statement
Profit margin
-11.31%
Return on assets (ttm)
-6.04%
Return on equity (ttm)
-52.91%
Revenue (ttm)
25.41M
Net income avi to common (ttm)
-2.87M
Diluted EPS (ttm)
-0.0100
Balance sheet and cash flow
Total cash (mrq)
3.46M
Total debt/equity (mrq)
195.19%
Levered free cash flow (ttm)
-1.95M